Loading...
Sekisui Chemical Co., Ltd.
4204.T•JPX
Industrials
Conglomerates
¥2588.00
¥-44.50(-1.69%)
Sekisui Chemical Co., Ltd. (4204.T) Financial Performance & Income Statement Overview
Review Sekisui Chemical Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.28%
↑ 3.28%
Operating Income Growth
14.36%
↑ 14.36%
Net Income Growth
5.13%
↑ 5.13%
Operating Cash Flow Growth
11.82%
↑ 11.82%
Operating Margin
8.32%
↑ 8.32%
Gross Margin
32.41%
↑ 32.41%
Net Profit Margin
6.31%
↑ 6.31%
ROE
10.20%
↑ 10.20%
ROIC
10.90%
↑ 10.90%
Sekisui Chemical Co., Ltd. (4204.T) Income Statement & Financial Overview
Review Sekisui Chemical Co., Ltd.'s (4204.T) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $342.41B | $326.29B | $330.23B | $298.83B |
Cost of Revenue | $232.21B | $218.68B | $223.55B | $202.70B |
Gross Profit | $110.20B | $107.60B | $106.68B | $96.13B |
Gross Profit Ratio | $0.32 | $0.33 | $0.32 | $0.32 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $79.61B | $78.97B | $78.15B | $75.93B |
Operating Expenses | $79.61B | $78.97B | $78.15B | $75.93B |
Total Costs & Expenses | $311.82B | $297.65B | $301.70B | $278.63B |
Interest Income | $577.00M | $0.00 | $555.00M | $466.00M |
Interest Expense | $289.00M | $0.00 | $289.00M | $242.00M |
Depreciation & Amortization | $13.88B | $13.55B | $13.25B | $13.08B |
EBITDA | $35.41B | $42.19B | $41.06B | $33.28B |
EBITDA Ratio | $0.10 | $0.13 | $0.12 | $0.11 |
Operating Income | $30.59B | $28.64B | $28.52B | $20.20B |
Operating Income Ratio | $0.09 | $0.09 | $0.09 | $0.07 |
Other Income/Expenses (Net) | -$9.35B | $8.61B | -$1.24B | $14.007B |
Income Before Tax | $21.24B | $37.24B | $27.28B | $34.20B |
Income Before Tax Ratio | $0.06 | $0.11 | $0.08 | $0.11 |
Income Tax Expense | $7.25B | $11.09B | $7.46B | $10.07B |
Net Income | $13.43B | $25.57B | $19.21B | $23.71B |
Net Income Ratio | $0.04 | $0.08 | $0.06 | $0.08 |
EPS | $32.19 | $61.12 | $46.05 | $56.47 |
Diluted EPS | $32.19 | $61.12 | $46.05 | $56.47 |
Weighted Avg Shares Outstanding | $417.15M | $418.33M | $417.22M | $419.94M |
Weighted Avg Shares Outstanding (Diluted) | $417.15M | $418.33M | $417.22M | $419.94M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan